medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 3

Next >>

Med Int Mex 2021; 37 (3)

The evolution of the response of anti-SARSCoV- 2 antibodies in infected subjects

Ximénez-García C, Ramiro HM

Language: Spanish
References: 33
Page: 311-312
PDF size: 186.55 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37 (12): 1595-607. doi. 10.2337/diab.37.12.1595.

  2. Ferrannini E. Metabolic syndrome: A solution in search of a problem. J Clin Endocrinol Metab 2007; 92 (2): 396-8. doi. 10.1210/jc.2006-0944.

  3. Rodríguez AL, Sánchez M, Martínez L. Síndrome metabólico. Rev Cuba Endocrinol 2002; 13 (3).

  4. Morales-Villegas E. Síndrome X vs síndrome metabólico: Entendiendo sus coincidencias y sus diferencias hacia una “nueva cardiología”. Arch Cardiol Méx 2006; 76 (Supl. 4).

  5. Punthakee Z, Goldenberg R, Katz P. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2018; 42: S10-5. doi. 10.1016/j. jcjd.2017.10.003.

  6. Saad M, Cardoso G, Martins W, Velarde L, et al. Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria. Arq Bras Cardiol. 2014; 102 (3): 263-269. doi. 10.5935/abc.20140013.

  7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112 (17): 2735-52. doi. 10.1161/CIRCULATIONAHA.105.169404.

  8. Alberti K, Eckel R, Grundy S, Zimmet P, et al. Harmonizing the metabolic syndrome. Circulation 2009; 120 (16): 1640- 5. doi. 10.1161/CIRCULATIONAHA.109.192644.

  9. Gurka MJ, Filipp SL, DeBoer MD. Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults. Nutr Diabetes 2018; 8 (1): 14. doi. 10.1038/s41387-018-0024-2.

  10. Márquez S, Macedo G, Viramontes D, Ballart F, et al. The prevalence of metabolic syndrome in Latin America: A systematic review. Public Health Nutr 2011; 14 (10): 1702-13. doi. 10.1017/S1368980010003320.

  11. Shin D, Kongpakpaisarn K, Bohra C. Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014. Int J Cardiol 2018; 259: 216-9. doi. https://doi.org/10.1016/j.ijcard.2018.01.139.

  12. Sue S. Prevalence trend of metabolic syndrome in younger vs. older Chinese adults: a systematic review and metaanalysis. Soc Acad Prim Care 2018; 1 (1).

  13. Cuevas A, Alvarez V, Carrasco F. Epidemic of metabolic syndrome in Latin America. Curr Opin Endocrinol Diabetes Obes 2011; 18 (2): 134-8. doi. 10.1097/ MED.0b013e3283449167.

  14. Pico S, Bergonzoli G, Contreras A. Risk factors associated with metabolic syndrome in Cali, Colombia. Biomédica 2018; 39 (1). https://doi.org/10.7705/biomedica. v39i1.3935.

  15. McNerney R. Diagnostics for developing countries. Diagnostics (Basels) 2015; 5 (2): 200-9. doi. 10.3390/ diagnostics5020200.

  16. Pai N, Vadnais C, Denkinger C, Engel N, et al. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low-and middle-income countries. PLOS Med 2012; 9 (9): e1001306. doi. 10.1371/journal.pmed.1001306.

  17. Cook RJ. Encyclopedia of Biostatistics. En: Armitage P, Colton T, editores. Encyclopedia of Biostatistics. Chichester, UK: John Wiley & Sons, Ltd; 2005.

  18. Landis R, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1): 159-74.

  19. Burgos M, Manterola C. Cómo interpretar pruebas diagnósticas. Rev Chil Cir 2010; 62 (3): 301-8. http://dx.doi. org/10.4067/S0718-40262010000300018.

  20. Matfin G. The metabolic syndrome: what’s in a name? Ther Adv Endocrinol Metab 2010; 1 (2): 39-45. doi. 10.1177/2042018810374290.

  21. Paternina Á, Alcalá G, Paillier J, Romero Á, et al. Concordancia de tres definiciones de síndrome metabólico en pacientes hipertensos. Rev Salud Pública 2009; 11 (6): 898-908. doi. 10.1590/S0124-00642009000600006.

  22. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83 (6): 1237-47. doi. 10.1093/ajcn/83.6.1237.

  23. Restrepo J, Silva C, Andrade F, VH-Dover R. Acceso a servicios de salud: análisis de barreras y estrategias en el caso de Medellín, Colombia. Gerenc Políticas Salud 2014; 13 (27). doi. 10.11144/Javeriana.rgyps13-27.assa.

  24. Hernández J, Rubiano D, Barona J. Barreras de acceso administrativo a los servicios de salud en población colombiana, 2013. Ciênc Saúde Coletiva 2015; 20 (6): 1947-58. https:// doi.org/10.1590/1413-81232015206.12122014.

  25. Mora-García G, Salguedo-Madrid G, Ruíz-Díaz M, Ramos- Clason E, et al. Concordancia entre cinco definiciones de síndrome metabólico. Rev Esp Salud Pública 2012; 86 (3): 301-11.

  26. Aschner P, Ruiz A, Balkau B, Massien C, et al. Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America. J Clin Hypertens 2009; 11 (12): 769-74. doi. 10.1111/j.1559-4572.2008.00051.x.

  27. Avezum Á, Perel P, Oliveira GBF, Lopez-Jaramillo P, et al. Challenges and opportunities to scale up cardiovascular disease secondary prevention in Latin America and the Caribbean. Glob Heart 2018; 13 (2): 83-91. doi. 10.1016/j.gheart.2017.05.002.

  28. Camacho S, Maldonado N, Bustamante J, Llorente B, et al. How much for a broken heart? Costs of cardiovascular disease in Colombia using a person-based approach. Husain MJ, editor. PLOS One 2018; 13 (12): e0208513. doi. 10.1371/journal.pone.0208513.

  29. WHO | Publications on NCDs [Internet]. WHO. [citado 30 de julio de 2019]. Disponible en: http://www.who.int/ nmh/publications/en/.

  30. Cabrera E, Stusser B, Cálix W, Orlandi N, et al. Concordancia diagnóstica entre siete criterios de síndrome metabólico en adultos con sobrepeso y obesidad. Rev Peru Med Exp Salud Pública 2017; 34 (1): 19. http://dx.doi.org/10.17843/ rpmesp.2017.341.2763.

  31. Gaitán H, Rubio J, Chantraine M. Interpreting obstetric and gynaecological disease screening and diagnostic test performance. Rev Colomb Obstet Ginecol 2009; 60 (4).

  32. Ferreira A, Ramírez C, Mendoza V, Molina M. Utility of the waist-to-height ratio, waist circumference and body mass index in the screening of metabolic syndrome in adult patients with type 1 diabetes mellitus. Diabetol Metab Syndr 2014; 6: 32. doi. 10.1186/1758-5996-6-32.

  33. Rodríguez M, Mendoza M, Sirtori AM, Caballero I, et al. Riesgo de diabetes mellitus tipo 2, sobrepeso y obesidad en adultos del Distrito de Barranquilla. RESPYN Rev Salud Pública Nutr 2018; 17 (4): 1-10. doi. https://doi. org/10.29105/respyn17.4-1.




2020     |     www.medigraphic.com